FedEx Express, a subsidiary of FedEx Corp, has officially opened its 'FedEx Life Science Center' in Mumbai, a dedicated facility specializing in clinical trial supply chain services.

This center is designed to meet the storage and logistics requirements of healthcare clients in India and worldwide, adhering to rigorous industry regulations and quality standards.

Key features of the center include comprehensive coverage of temperature-controlled zones, 24/7 monitoring capabilities, specialized destruction services for returned products, and a commitment to maintaining high-quality service through robust quality management systems.

FedEx, known for its extensive door-to-door delivery network, currently serves over 6,000 postal codes in India, ensuring express delivery within 24 to 48 hours in major metropolitan areas.

For critical pharmaceutical shipments, FedEx Customized Freight (FCF) provides premium services that prioritize product integrity and regulatory compliance.

Customers seeking extra assurances for time-sensitive shipments can opt for FedEx Priority Alert Plus, offering continuous monitoring and personalized guidance in case of any delays.

Nitin Navneet Tatiwala, Vice President of FedEx Express, Marketing, Middle East, India Sub-continent & Africa (MEISA), emphasized the significance of the new Life Science Center, stating, "FedEx Life Science Center (LSC) in India will focus on clinical trial storage and distribution. The new center joins FedEx’s global network of LSCs in Japan, South Korea, Singapore, the USA, and the Netherlands." The establishment of this center is expected to enhance FedEx's capabilities in providing specialized services for the healthcare and life sciences sector, contributing to the seamless and efficient management of clinical trial logistics.